EGFR等体细胞基因突变检测技术最新研究进展_PPT课件.pptVIP

JY Zhao zhaojy526@ ; Characterizing early and posttreatment tumor status in cancer patients drug-resistant strains detection from clinical samples of infectious disease patients ;IT is difficult! Why?;; To detect low-level early mutations (e.g., 10e–3 to 10e–6 mutant to wild-type DNA), both high selectivity and enrichment of minority alleles are required for successful detection and identification For a particular approach to be used as a routine diagnostic tool, it must achieve